(Q38070878)

28 August 2017

1 reference

title

The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy (English)

1 reference

28 August 2017

Hugh J Willison

1

1 reference

28 August 2017

publication date

1 December 2012

1 reference

Journal of the Peripheral Nervous System

28 August 2017

published in

1 reference

28 August 2017

volume

17 Suppl 3

1 reference

28 August 2017

page(s)

3-8

1 reference

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

An acute axonal form of Guillain-Barré polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Serum antibodies to gangliosides in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Peripheral neuropathies and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Pathology of the motor-sensory axonal Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8027.2012.00423.X

10.1111/J.1529-8027.2012.00423.X

21 January 2018

Identifiers

DOI

1 reference

release_jzc5slgxuzhkzn43ydwa3gw7nq

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jzc5slgxuzhkzn43ydwa3gw7nq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference